What's breaking now, across thousands of outlets.
Early indicators from a compassionate use plan led analysts to hike projections for daraxonrasib. Elsewhere, Intellia believes it’s answered a key safety question and Arrowhead moved to catch a rival.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
A new study suggests that for people with dark personality traits, problematic social media use is often tied to relationship jealousy. For these individuals, compulsive scrolling frequently involves suspicious thoughts and cyberstalking their romantic partners.
For decades, pulse oximeters have been among medicine's most familiar instruments. Clip one onto a finger, and within seconds it reports how much oxygen is in your blood, a vital indicator of health.
by Joseph Kamtchum-Tatuene, James Farrell, John Nolan, Sarah Lessels, William N. Whiteley, Linxin Li, on behalf of the CVD-COVID-UK/COVID-IMPACT Consortium Background The incidence of stroke at…
Communication in clinical trials can make or break research and development. Learn how a formal communication plan and a culture of transparency can protect research outcomes.
The trial seeks to evaluate the effectiveness and safety of using psilocybin to treat depression in veterans.
Experts called on healthcare workers to promote breastfeeding and protect parents and children from the commercial milk formula industry’s influences at a panel discussion for World Breastfeeding Week.
